CompaniesLumiraDx

LumiraDx

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

700

By Status

ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT03561051Collaborator

The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study

N/AActive, not recruiting

700 participants

Started: Oct 16, 2018 · Completed: Jan 1, 2025

Funding History (10)

DRS

Jun 21, 2022

DRS/A

Jun 16, 2021

DRSLTR

Jun 15, 2021

DRS

Apr 20, 2021

DRS/A

Dec 23, 2020

D

Dec 15, 2020

DRS/A

Oct 14, 2020

DRS/A

Sep 10, 2020

DRS

Aug 3, 2020

D/A

May 28, 2020

Related Companies

Roche

acquired

LumiraDx | Biotech Hunter | Biotech Hunter